Cordis brings two new catheters to U.S. market

TriMed Staff | | Health Imaging | Screening
Cordis, a subsidiary of Johnson & Johnson, has introduced its Fire Star Rx PTCA Dilatation Catheter and its Dura Star Rx PTCA Dilatation Catheter into the U.S. market.

The U.S. FDA approved the commercialization of these products in late August.

According to the Miami Lakes, Fla.-based Cordis, the Fire Star balloon features a low pre-dilatation profile and the Dura Star balloon is suited for use with both drug-eluting and bare metal balloon-expandable stents.

Both balloons will be offered to catheterization laboratories and interventional cardiologists on Oct. 15.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.